Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia

被引:0
|
作者
Vivi Lisdawati
Nelly Puspandari
Lutfah Rif’ati
Triyani Soekarno
Melatiwati M
Syamsidar K
Lies Ratnasari
Nur Izzatun
Ida Parwati
机构
[1] Institute for Vector and Reservoir Disease Control Research and Development (IVRDCRD),Department of Clinical Pathology
[2] Center for Biomedical and Basic Technology of Health (CBBTH),undefined
[3] NIHRD,undefined
[4] MoH-RI,undefined
[5] Dr. Hasan Sadikin Hospital,undefined
来源
关键词
Personal Protective Equipment; Primary Health Center; Sputum Specimen; Beijing Strain; Beijing Family;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs
    Alba Alvarez, Luz Maria
    Garcia Garcia, Jose Maria
    Dolores Perez Hernandez, M.
    Martinez Gonzalez, Susana
    Palacios Gutierrez, Juan Jose
    [J]. ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (04): : 192 - 198
  • [22] Molecular Analysis of Anti-Tuberculosis Drug Resistance of Mycobacterium tuberculosis Isolated in the Republic of Korea
    Jeon, Se-Mi
    Park, Sanghee
    Lim, Na-Ra
    Lee, Noori
    Jung, Jihee
    Sung, Nackmoon
    Kim, Seonghan
    [J]. ANTIBIOTICS-BASEL, 2023, 12 (08):
  • [23] Validation of Mycobacterium tuberculosis dihydroneopterin aldolase as a molecular target for anti-tuberculosis drug development
    Falcao, V. C. A.
    Villela, A. D.
    Rodrigues-Junior, V. S.
    Pissinate, K.
    Eichler, P.
    Pinto, A. F. M.
    Basso, L. A.
    Santos, D. S.
    Bizarro, C. V.
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 485 (04) : 814 - 819
  • [24] MIC distribution of anti-tuberculosis drugs in Mycobacterium tuberculosis clinical isolates from cPMTb cohort
    Park, Yumi
    Lee, Sunyoung
    Cho, Yong-Soon
    Kim, Jusang
    Oh, Jee Youn
    Jang, Tae-Won
    Min, Jinsoo
    Kim, Hyun-Kuk
    Kim, Ho Cheol
    Lee, Heayon
    Lee, Jaehee
    Ko, Yousang
    Kim, Jin Woo
    Lee, Hyun-Kyung
    Park, Hye Kyeong
    Mok, Jeongha
    Shin, Kyeong-Cheol
    Shin, Jae-Gook
    [J]. RESPIROLOGY, 2023, 28 : 241 - 241
  • [25] Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997
    Abe, C
    Hirano, K
    Wada, M
    Aoyagi, T
    [J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2001, 5 (01) : 46 - 52
  • [26] Oral anti-tuberculosis drugs: An urgent medication reconciliation at hospitals in Indonesia
    Herawati, Fauna
    Fahmi, Eka Yuliantini
    Pratiwi, Noer Aulia
    Ramdani, Dewi
    Jaelani, Abdul Kadir
    Yulia, Rika
    Andrajati, Retnosari
    [J]. JOURNAL OF PUBLIC HEALTH RESEARCH, 2021, 10 (03)
  • [27] Metabolic Changes of Mycobacterium tuberculosis during the Anti-Tuberculosis Therapy
    Bespyatykh, Julia
    Shitikov, Egor
    Bespiatykh, Dmitry
    Guliaev, Andrei
    Klimina, Ksenia
    Veselovsky, Vladimir
    Arapidi, Georgij
    Dogonadze, Marine
    Zhuravlev, Viacheslav
    Ilina, Elena
    Govorun, Vadim
    [J]. PATHOGENS, 2020, 9 (02):
  • [28] Cause Of Anti-Tuberculosis Drugs Discontinuation
    Ohashi, K.
    Takamori, M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [29] ANTI-TUBERCULOSIS DRUGS USED IN COMBINATIONS
    不详
    [J]. HSMHA HEALTH REPORTS, 1971, 86 (10): : 896 - &
  • [30] Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis
    Abbadi, Said H.
    Sameaa, G. Abdel
    Morlock, G.
    Cooksey, R. C.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (06) : 673 - 678